Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Condition: Kidney Transplant Infection Intervention: Drug: ROVALCYTE Sponsor: University Hospital, Rouen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cytomegalovirus | Hospitals | Research | Transplant Surgery | Transplants | Urology & Nephrology